Brief: ImmuCell Reports Q3 Loss Per Share Of $0.04
Nov 12 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE
THIRD
QUARTER ENDED SEPTEMBER 30, 2020
* Q3 LOSS PER SHARE $0.04
* QTRLY TOTAL PRODUCT SALES INCREASED BY 25% TO $3.7 MILLION
Source text for Eikon: ID:nGNXhQM7S
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year